Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$161.15
-1.87-1.15%
al cierre: -
$160.42
-0.73-0.45%
After hour: 7:28 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Natera Inc ha un obiettivo di prezzo di consenso pari a $176.4, stabilito in base alle ultime valutazioni degli analisti di 21. Le ultime 3 valutazioni degli analisti sono state rilasciate da Stephens & Co., Piper Sandler y RBC Capital il agosto 15, 2025, agosto 11, 2025 y agosto 8, 2025. Con un obiettivo di prezzo medio di $219.33 tra le Stephens & Co., Piper Sandler y RBC Capital, c'è un implicito 36.72% upside per Natera Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Stephens & Co.
Piper Sandler
RBC Capital
Barclays
Evercore ISI Group
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Natera
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/15/2025 | 14.08% | Stephens & Co. | $183 → $183 | Reiterates | Overweight → Overweight | |||
08/11/2025 | 37.14% | Piper Sandler | $210 → $220 | Maintains | Overweight | |||
08/08/2025 | 58.96% | RBC Capital | $251 → $255 | Maintains | Outperform | |||
08/08/2025 | 30.91% | Barclays | $190 → $210 | Maintains | Overweight | |||
07/28/2025 | 5.97% | Evercore ISI Group | → $170 | Initiates | → Outperform | |||
05/15/2025 | 30.91% | Piper Sandler | $205 → $210 | Maintains | Overweight | |||
05/09/2025 | 35.89% | UBS | $211 → $218 | Maintains | Buy | |||
05/09/2025 | 18.44% | Barclays | $160 → $190 | Maintains | Overweight | |||
04/10/2025 | -0.26% | Barclays | $200 → $160 | Maintains | Overweight | |||
03/13/2025 | 56.46% | RBC Capital | → $251 | Initiates | → Outperform | |||
03/05/2025 | 15.32% | Morgan Stanley | $176 → $185 | Maintains | Overweight | |||
03/04/2025 | 27.79% | Piper Sandler | $200 → $205 | Maintains | Overweight | |||
02/28/2025 | 21.56% | Canaccord Genuity | $180 → $195 | Maintains | Buy | |||
02/28/2025 | 17.19% | Baird | $183 → $188 | Maintains | Outperform | |||
02/26/2025 | 12.21% | Canaccord Genuity | $180 → $180 | Maintains | Buy | |||
01/28/2025 | 18.44% | Goldman Sachs | $160 → $190 | Maintains | Buy | |||
01/23/2025 | 24.67% | Barclays | → $200 | Initiates | → Overweight | |||
01/17/2025 | 24.67% | Guggenheim | $170 → $200 | Maintains | Buy | |||
01/10/2025 | 24.67% | Bernstein | $160 → $200 | Maintains | Outperform | |||
01/03/2025 | 12.21% | Canaccord Genuity | $165 → $180 | Maintains | Buy | |||
12/13/2024 | 24.67% | JP Morgan | $160 → $200 | Maintains | Overweight | |||
11/18/2024 | 24.67% | Piper Sandler | $150 → $200 | Maintains | Overweight | |||
11/14/2024 | 9.71% | Morgan Stanley | $132 → $176 | Maintains | Overweight | |||
11/13/2024 | 9.09% | TD Cowen | $155 → $175 | Maintains | Buy | |||
11/13/2024 | -2.13% | Craig-Hallum | $121 → $157 | Maintains | Buy | |||
11/13/2024 | -0.26% | JP Morgan | $135 → $160 | Maintains | Overweight | |||
11/13/2024 | 2.86% | Canaccord Genuity | $150 → $165 | Maintains | Buy | |||
11/13/2024 | -0.26% | Baird | $120 → $160 | Maintains | Outperform | |||
10/30/2024 | -15.85% | Bernstein | $125 → $135 | Maintains | Outperform | |||
10/29/2024 | -6.5% | Canaccord Genuity | $145 → $150 | Maintains | Buy | |||
10/17/2024 | -6.5% | Leerink Partners | $140 → $150 | Maintains | Outperform | |||
10/16/2024 | -12.73% | Goldman Sachs | $125 → $140 | Maintains | Buy | |||
09/13/2024 | -6.5% | Piper Sandler | $150 → $150 | Reiterates | Overweight → Overweight | |||
08/27/2024 | -9.61% | Canaccord Genuity | $130 → $145 | Maintains | Buy | |||
08/13/2024 | -17.72% | Morgan Stanley | $125 → $132 | Maintains | Overweight | |||
08/13/2024 | -6.5% | Piper Sandler | $120 → $150 | Maintains | Overweight | |||
08/09/2024 | -9.61% | TD Cowen | $137 → $145 | Maintains | Buy | |||
08/09/2024 | -15.85% | BTIG | $125 → $135 | Maintains | Buy | |||
08/09/2024 | -22.08% | Stephens & Co. | $125 → $125 | Reiterates | Overweight → Overweight | |||
08/09/2024 | -9.61% | UBS | $160 → $145 | Maintains | Buy | |||
08/09/2024 | -25.2% | Baird | $117 → $120 | Maintains | Outperform | |||
06/03/2024 | -11.48% | Jefferies | → $142 | Initiates | → Buy | |||
05/14/2024 | -25.2% | Piper Sandler | $110 → $120 | Maintains | Overweight | |||
05/13/2024 | -22.08% | BTIG | $100 → $125 | Maintains | Buy | |||
05/10/2024 | -18.96% | Canaccord Genuity | $100 → $130 | Maintains | Buy | |||
05/10/2024 | -14.6% | TD Cowen | $123 → $137 | Maintains | Buy | |||
05/10/2024 | -27.07% | Baird | $99 → $117 | Maintains | Outperform | |||
04/15/2024 | -37.66% | Goldman Sachs | $90 → $100 | Maintains | Buy | |||
04/08/2024 | -27.07% | Craig-Hallum | → $117 | Assumes | → Buy | |||
04/05/2024 | -25.2% | Bernstein | → $120 | Upgrade | Market Perform → Outperform | |||
03/06/2024 | -31.43% | Piper Sandler | $70 → $110 | Maintains | Overweight | |||
02/29/2024 | -43.9% | Goldman Sachs | $80 → $90 | Maintains | Buy | |||
02/29/2024 | -37.66% | Canaccord Genuity | $87 → $100 | Maintains | Buy | |||
02/27/2024 | -43.9% | BTIG | $85 → $90 | Maintains | Buy | |||
02/20/2024 | -47.01% | Raymond James | $68 → $85 | Downgrade | Strong Buy → Outperform | |||
01/30/2024 | -51.38% | Stephens & Co. | $78 → $78 | Reiterates | Overweight → Overweight | |||
01/30/2024 | -50.13% | Goldman Sachs | $64 → $80 | Maintains | Buy | |||
01/29/2024 | -50.13% | Goldman Sachs | $64 → $80 | Maintains | Buy | |||
01/17/2024 | -51.38% | Stephens & Co. | $78 → $78 | Reiterates | Overweight → Overweight | |||
12/29/2023 | -47.01% | BTIG | $75 → $85 | Maintains | Buy | |||
12/29/2023 | -60.1% | Goldman Sachs | $56 → $64 | Maintains | Buy | |||
12/14/2023 | -56.36% | Guggenheim | → $70 | Initiates | → Buy | |||
12/13/2023 | — | Wolfe Research | — | Initiates | → Outperform | |||
12/12/2023 | -45.77% | TD Cowen | $82 → $87 | Maintains | Outperform | |||
11/13/2023 | -57.61% | Raymond James | → $68 | Upgrade | Outperform → Strong Buy | |||
11/10/2023 | -57.61% | Morgan Stanley | $70 → $68 | Maintains | Overweight | |||
11/09/2023 | -56.36% | UBS | $76 → $70 | Maintains | Buy | |||
10/20/2023 | -67.59% | Goldman Sachs | $60 → $52 | Maintains | Buy | |||
10/16/2023 | -56.36% | Piper Sandler | $80 → $70 | Maintains | Overweight | |||
09/28/2023 | -70.08% | Bernstein | → $48 | Initiates | → Market Perform | |||
08/08/2023 | -50.13% | Piper Sandler | $70 → $80 | Maintains | Overweight | |||
08/07/2023 | -56.36% | Morgan Stanley | $72 → $70 | Maintains | Overweight | |||
08/04/2023 | -56.36% | Credit Suisse | → $70 | Reiterates | Outperform → Outperform | |||
07/24/2023 | -62.6% | Goldman Sachs | $70 → $60 | Maintains | Buy | |||
07/21/2023 | -62.6% | Goldman Sachs | $70 → $60 | Maintains | Buy | |||
05/30/2023 | -56.36% | Piper Sandler | $80 → $70 | Maintains | Overweight | |||
05/10/2023 | -50.13% | Piper Sandler | → $80 | Maintains | Overweight | |||
05/10/2023 | -56.36% | Credit Suisse | $65 → $70 | Maintains | Outperform | |||
05/10/2023 | -56.36% | Goldman Sachs | $80 → $70 | Maintains | Buy | |||
05/10/2023 | -58.86% | Baird | $65 → $66 | Maintains | Outperform | |||
05/05/2023 | -52.62% | UBS | → $76 | Initiates | → Buy | |||
03/03/2023 | -57.61% | Raymond James | $58 → $68 | Maintains | Outperform | |||
03/02/2023 | -55.12% | Morgan Stanley | $70 → $72 | Maintains | Overweight | |||
03/01/2023 | -59.48% | Credit Suisse | $55 → $65 | Maintains | Outperform | |||
01/18/2023 | -63.84% | Raymond James | → $58 | Upgrade | Market Perform → Outperform | |||
01/17/2023 | -56.36% | Piper Sandler | → $70 | Maintains | Overweight | |||
11/14/2022 | -65.71% | Credit Suisse | $70 → $55 | Maintains | Outperform | |||
08/25/2022 | -56.36% | Credit Suisse | → $70 | Initiates | → Outperform |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Natera (NTRA)?
El último precio objetivo de Natera (NASDAQ:NTRA) fue comunicado por Stephens & Co. el agosto 15, 2025. La firma de analistas fijó un precio objetivo para $183.00 que espera NTRA a rise dentro de 12 meses (un posible 14.08% upside). 34 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Natera (NTRA)?
La última calificación de analistas para Natera (NASDAQ:NTRA) fue proporcionada por Stephens & Co., y Natera reiterado su overweight calificación.
¿Cuándo se produjo la última revisión al alza de Natera (NTRA)?
La última revisión al alza de Natera Inc se produjo en abril 5, 2024, cuando Bernstein elevó su precio objetivo a $120. Bernstein anteriormente tenía a market perform para Natera Inc.
¿Cuándo fue la última revisión a la baja de Natera (NTRA)?
La última revisión a la baja de Natera Inc se produjo en febrero 20, 2024, cuando Raymond James cambió su precio objetivo de $68 a $85 para Natera Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Natera (NTRA)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Natera, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Natera se registró el agosto 15, 2025, por lo que la próxima calificación estará disponible en torno al agosto 15, 2026.
¿Es correcta la calificación de los analistas sobre Natera (NTRA)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Natera (NTRA) fue un reiterado con un precio objetivo de $183.00 a $183.00. El precio actual al que cotiza Natera (NTRA) es de $160.42, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.